Larson G, Falk P, Hoskins L C
Department of Clinical Chemistry, Gothenburg University, Sahlgren's Hospital, Sweden.
J Biol Chem. 1988 Aug 5;263(22):10790-8.
Certain normal strains of human fecal bacteria are unique in producing extracellular glycosidases that degrade the oligosaccharide chains of gut mucin glycoproteins. We have studied the action of such glycosidases partially purified from the cell-free supernates of five of these strains on intestinal glycosphingolipids isolated from human meconium. The glycolipids were sialosyl-lactosylceramide, lactosylceramide, and fucolipids with A, B, H, Lea, or Leb blood group determinants. In addition to the strain-specific high blood group A-degrading activities (Ruminococcus torques strains VIII-239 and IX-70), B-degrading activity (Ruminococcus AB strain VI-268), and H-degrading activities (all strains) corresponding to alpha 1-3-N-acetylgalactosaminidase, alpha 1-3-galactosidase and alpha 1-2-fucosidase, respectively, all strains also degraded sialosyl-lactosylceramide and Lea and Leb antigenic glycolipids, indicating the presence of alpha 2-3-neuraminidases and alpha 1-4-fucosidases. Enzyme preparations from Bifidobacterium infantis strain VIII-240 and R. torques strain VIII-239 hydrolyzed the Lea active glycolipid directly to lactosylceramide, suggesting the presence of endo-beta 1-3-N-acetylglucosaminidase activities. Similar endo-beta-N-acetylglucosaminidase activities were identified in four of the five enzyme preparations. The enzymes produced by R. AB strain VI-268 lacked this activity as well as beta 1-3-galactosidase, and thus degradation stopped at lactotetraosylceramide. With enzyme preparations from the other strains lactosylceramide was the single major degradation product from complex glycosphingolipids with less than 30% further degradation to glucosylceramide within 48 h. We conclude that glycosidases from mucin-degrading strains of human enteric bacteria degrade oligosaccharide chains of lactoseries fucolipids and gangliosides of intestinal origin primarily to lactosylceramide. Since several genera of enteric bacteria bind preferentially to lactosylceramide in vitro, mucin-degrading strains may have an important ecological role in host-microbial associations in the human gut.
某些正常的人类粪便细菌菌株在产生能降解肠道粘蛋白糖蛋白寡糖链的细胞外糖苷酶方面具有独特性。我们研究了从其中五个菌株的无细胞上清液中部分纯化得到的此类糖苷酶对从人胎粪中分离出的肠道糖鞘脂的作用。这些糖脂是唾液酸乳糖基神经酰胺、乳糖基神经酰胺以及带有A、B、H、Lea或Leb血型决定簇的岩藻糖脂。除了菌株特异性的高血型A降解活性(扭链瘤胃球菌菌株VIII - 239和IX - 70)、B降解活性(AB型瘤胃球菌菌株VI - 268)以及H降解活性(所有菌株),分别对应α1 - 3 - N - 乙酰半乳糖胺酶、α1 - 3 - 半乳糖苷酶和α1 - 2 - 岩藻糖苷酶外,所有菌株还降解唾液酸乳糖基神经酰胺以及Lea和Leb抗原性糖脂,这表明存在α2 - 3 - 神经氨酸酶和α1 - 4 - 岩藻糖苷酶。婴儿双歧杆菌菌株VIII - 240和扭链瘤胃球菌菌株VIII - 239的酶制剂将具有Lea活性的糖脂直接水解为乳糖基神经酰胺,这表明存在内切β1 - 3 - N - 乙酰葡糖胺酶活性。在五种酶制剂中的四种中鉴定出了类似的内切β - N - 乙酰葡糖胺酶活性。AB型瘤胃球菌菌株VI - 268产生的酶缺乏这种活性以及β1 - 3 - 半乳糖苷酶,因此降解在乳糖四糖基神经酰胺处停止。对于其他菌株的酶制剂,乳糖基神经酰胺是复杂糖鞘脂的单一主要降解产物,在48小时内进一步降解为葡糖基神经酰胺的比例不到30%。我们得出结论,来自人肠道细菌中降解粘蛋白的菌株的糖苷酶主要将肠道来源的乳糖系列岩藻糖脂和神经节苷脂的寡糖链降解为乳糖基神经酰胺。由于几种肠道细菌属在体外优先与乳糖基神经酰胺结合,降解粘蛋白的菌株可能在人类肠道中宿主 - 微生物关联中具有重要的生态作用。